Masimo, Mobilize Recovery Join Forces for 2024 Bus Tour

Masimo is partnering with Mobilize Recovery, a nonprofit organization dedicated to ending America’s addiction and overdose crisis. Masimo will sponsor and join the Mobilize Recovery 2024 bus tour.
 
Mobilize Recovery was founded by Ryan Hampton. It brings together recovery advocates, nonprofit organizations, allies, business leaders and innovators like Masimo, government partners, and like-minded community-based organizations with interest in creating sustainable change and community solutions, as well as celebrating recovery from substance abuse disorder and mental health challenges.
 
The tour begins September 20 in Los Angeles, with the first stop at the Masimo headquarters in Irvine. It’s then set to travel to 15 key U.S. cities to raise awareness, educate, and support communities around the country.
 
Its sixth annual initiative will showcase Masimo’s Opioid Halo and Bridge, designed to help people using opioids stay safe and reduce withdrawal symptoms during recovery, respectively.
 
Opioid Halo is an opioid overdose prevention and alert system granted U.S. Food and Drug Administration (FDA) de novo clearance in 2023. Its Opioid Halo engine is an advanced pattern recognition algorithm that helps spot and quantify the risk of severe opioid-induced respiratory depression (OIRD). It helps manage and send escalating alarms to loved ones to notify that help might be needed for an opioid overdose. It also triggers an automatic wellness call, which might lead to dispatch of EMS.
 
Bridge uses neuromodulation to help reduce opioid withdrawal symptoms. Bridge also obtained a de novo from the FDA in 2020 as the first evidence-based, drug-free, non-surgical device of its kind. It fits behind the ear, applied by a clinician in a short, non-surgical procedure. Bridge sends electrical impulses to nerves near the ear, transmitting them to the brain and offering up to five days of continuous relief from withdrawal symptoms.
 
Ryan Hampton, founder and executive director of Mobilize Recovery, said, “Mobilize Recovery champions a grassroots approach, empowering advocates, innovators, businesses, and communities battling the overdose crisis firsthand. We see Masimo as a leading innovation partner in the recovery movement, uniquely positioned to drive technological advancements that make a real impact. We’re thrilled to collaborate with a company so committed to leveraging technology for groundbreaking solutions in recovery. Masimo’s Opioid Halo and Bridge have shown immense promise in helping opioid users, and we’re eager to see their full potential realized. In Masimo’s CEO, Joe Kiani, we’ve found a passionate voice advocating for overcoming this epidemic, a true thought leader in the recovery field with an unwavering dedication to making a difference.”
 
Masimo founder and CEO Joe Kiani added, “We are excited to sponsor Mobilize Recovery, partner with their amazing team, and help kick off the bus tour in September. Masimo is committed to creating evidence-based solutions that fill in existing gaps in patient support networks. We were honored to be chosen by the FDA as a winner of their FDA Opioid Innovation Challenge for our solution to help prevent opioid overdose. With Opioid Halo, we became the first winner to have an authorized device to address the crisis. Bridge, in turn, is the first FDA-cleared medical device to help in the reduction of opioid withdrawal symptoms. Together, we believe these products, and the amazing efforts of Mobilize Recovery and its partners, can make a real difference in fighting the opioid crisis—as well as help eliminate the stigma around addiction.”